The new policy goes into effect in November, improving Medicare coverage for a technology that has rapidly gained momentum in recent years. The new policy goes into effect in November, improving Medicare coverage for a technology that has rapidly gained momentum in recent years. | |
|
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females. Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females. | |
|
A patient's blood type appears to play a major role in their odds of developing cardiovascular issues after COVID-19, researchers found. A patient's blood type appears to play a major role in their odds of developing cardiovascular issues after COVID-19, researchers found. | |
|
“This document represents a collective effort to refine and advance the standards of care in STEMI management," according to one cardiologist behind the project. “This document represents a collective effort to refine and advance the standards of care in STEMI management," according to one cardiologist behind the project. | |
|
The newly approved system includes a stent, dilation balloon and integrated embolic protection filter. After CMS expanded Medicare coverage for carotid artery stenting in 2023, the procedures are expected to grow more and more common as time goes on. The newly approved system includes a stent, dilation balloon and integrated embolic protection filter. After CMS expanded Medicare coverage for carotid artery stenting in 2023, the procedures are expected to grow more and more common as time goes on. | |
|
Device-based therapies can provide considerable value for heart failure patients when used alongside traditional pharmaceutical treatments. A new HFSA scientific statement outlines the benefits of these devices, urging care teams to implement them into daily practice. Device-based therapies can provide considerable value for heart failure patients when used alongside traditional pharmaceutical treatments. A new HFSA scientific statement outlines the benefits of these devices, urging care teams to implement them into daily practice. | |
|
The objective of the AHA scientific statement is to review the available evidence on for better management of cardiac arrhythmias from COVID causes that are still encountered on a regular basis. The objective of the AHA scientific statement is to review the available evidence on for better management of cardiac arrhythmias from COVID causes that are still encountered on a regular basis. | |
|
The 49-year-old patient was not in pain or suffering any complications, but he wished to have his extravascular ICD removed once his symptoms improved. The care team agreed to extract it after a long discussion, and they said it was "easier than expected." The 49-year-old patient was not in pain or suffering any complications, but he wished to have his extravascular ICD removed once his symptoms improved. The care team agreed to extract it after a long discussion, and they said it was "easier than expected." | |
|
iCardio.ai, co-founded by a cardiologist, is part of the Cedars-Sinai Accelerator program. The startup has already announced new partnerships with Viz.ai, Abbott and others in the cardiac health space. iCardio.ai, co-founded by a cardiologist, is part of the Cedars-Sinai Accelerator program. The startup has already announced new partnerships with Viz.ai, Abbott and others in the cardiac health space. | |
|
A new risk score shows potential to help cardiologists predict the risk of some TAVR complications before they happen, guiding important treatment decisions. A new risk score shows potential to help cardiologists predict the risk of some TAVR complications before they happen, guiding important treatment decisions. | |
|